ABSTRACT
Alcohol use disorder accounts for a growing worldwide health system concern. Alcohol causes damages to various organs, including intestine and liver, primarily involved in its absorption and metabolism. However, alcohol-related organ damage risk varies significantly among individuals, even when they report consuming comparable dosages of alcohol. Factor(s) that may modulate the risk of organ injuries from alcohol consumption could be responsible for inter-individual variations in susceptibility to alcohol-related organ damages. Accumulating evidence suggests disruptions in circadian rhythm can exacerbate alcohol-related organ damages. Here we investigated the interplay between alcohol, circadian rhythm, and key tissue cellular processes at baseline, after a regular and a shift in the light/dark cycle (LCD) in mice. Central/peripheral clock expression of core clock genes (CoClGs) was analyzed. We also studied circadian homeostasis of tissue cellular processes that are involved in damages from alcohol. These experiments reveal that alcohol affects the expression of CoClGs causing a central-peripheral dyssynchrony, amplified by shift in LCD. The observed circadian clock dyssynchrony was linked to circadian disorganization of key processes involved in the alcohol-related damages, particularly when alcohol was combined with LCD. These results offer insights into the mechanisms by which alcohol interacts with circadian rhythm disruption to promote organ injury.
Subject(s)
Circadian Rhythm , Ethanol , Homeostasis , Mice, Inbred C57BL , Animals , Homeostasis/drug effects , Circadian Rhythm/drug effects , Male , Ethanol/pharmacology , Circadian Clocks/drug effects , Mice , Liver/drug effects , Liver/metabolism , CLOCK Proteins/genetics , CLOCK Proteins/metabolism , Photoperiod , Alcohol Drinking/adverse effects , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolismABSTRACT
The dysregulation of circadian rhythm oscillation is a prominent feature of various solid tumors. Thus, clarifying the molecular mechanisms that maintain the circadian clock is important. In the present study, we revealed that the transcription factor forkhead box FOXK1 functions as an oncogene in breast cancer. We showed that FOXK1 recruits multiple transcription corepressor complexes, including NCoR/SMRT, SIN3A, NuRD, and REST/CoREST. Among them, the FOXK1/NCoR/SIN3A complex transcriptionally regulates a cohort of genes, including CLOCK, PER2, and CRY2, that are critically involved in the circadian rhythm. The complex promoted the proliferation of breast cancer cells by disturbing the circadian rhythm oscillation. Notably, the nuclear expression of FOXK1 was positively correlated with tumor grade. Insulin resistance gradually became more severe with tumor progression and was accompanied by the increased expression of OGT, which caused the nuclear translocation and increased expression of FOXK1. Additionally, we found that metformin downregulates FOXK1 and exports it from the nucleus, while HDAC inhibitors (HDACi) inhibit the FOXK1-related enzymatic activity. Combined treatment enhanced the expression of circadian clock genes through the regulation of FOXK1, thereby exerting an antitumor effect, indicating that highly nuclear FOXK1-expressing breast cancers are potential candidates for the combined application of metformin and HDACi.
Subject(s)
Breast Neoplasms , Circadian Rhythm , Forkhead Transcription Factors , Gene Expression Regulation, Neoplastic , Insulin Resistance , Humans , Breast Neoplasms/pathology , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/drug therapy , Female , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/metabolism , Animals , Circadian Rhythm/genetics , Cryptochromes/genetics , Cryptochromes/metabolism , Sin3 Histone Deacetylase and Corepressor Complex/genetics , Repressor Proteins/genetics , Repressor Proteins/metabolism , CLOCK Proteins/genetics , CLOCK Proteins/metabolism , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolism , Cell Proliferation , Cell Line, Tumor , Nuclear Receptor Co-Repressor 1/metabolism , Nuclear Receptor Co-Repressor 1/genetics , Histone Deacetylase Inhibitors/pharmacology , Mice , Carcinogenesis/genetics , MCF-7 Cells , Mice, NudeABSTRACT
Most mammalian cells have molecular circadian clocks that generate widespread rhythms in transcript and protein abundance. While circadian clocks are robust to fluctuations in the cellular environment, little is known about the mechanisms by which the circadian period compensates for fluctuating metabolic states. Here, we exploit the heterogeneity of single cells both in circadian period and a metabolic parameter-protein stability-to study their interdependence without the need for genetic manipulation. We generated cells expressing key circadian proteins (CRYPTOCHROME1/2 (CRY1/2) and PERIOD1/2 (PER1/2)) as endogenous fusions with fluorescent proteins and simultaneously monitored circadian rhythms and degradation in thousands of single cells. We found that the circadian period compensates for fluctuations in the turnover rates of circadian repressor proteins and uncovered possible mechanisms using a mathematical model. In addition, the stabilities of the repressor proteins are circadian phase dependent and correlate with the circadian period in a phase-dependent manner, in contrast to the prevailing model.
Subject(s)
Circadian Rhythm , Cryptochromes , Period Circadian Proteins , Single-Cell Analysis , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Circadian Rhythm/physiology , Cryptochromes/metabolism , Cryptochromes/genetics , Animals , Repressor Proteins/metabolism , Repressor Proteins/genetics , Circadian Clocks/physiology , Humans , Mice , Protein StabilityABSTRACT
Depression is associated with dysregulated circadian rhythms, but the role of intrinsic clocks in mood-controlling brain regions remains poorly understood. We found increased circadian negative loop and decreased positive clock regulators expression in the medial prefrontal cortex (mPFC) of a mouse model of depression, and a subsequent clock countermodulation by the rapid antidepressant ketamine. Selective Bmal1KO in CaMK2a excitatory neurons revealed that the functional mPFC clock is an essential factor for the development of a depression-like phenotype and ketamine effects. Per2 silencing in mPFC produced antidepressant-like effects, while REV-ERB agonism enhanced the depression-like phenotype and suppressed ketamine action. Pharmacological potentiation of clock positive modulator ROR elicited antidepressant-like effects, upregulating plasticity protein Homer1a, synaptic AMPA receptors expression and plasticity-related slow wave activity specifically in the mPFC. Our data demonstrate a critical role for mPFC molecular clock in regulating depression-like behavior and the therapeutic potential of clock pharmacological manipulations influencing glutamatergic-dependent plasticity.
Subject(s)
ARNTL Transcription Factors , Antidepressive Agents , Depression , Ketamine , Mice, Knockout , Prefrontal Cortex , Animals , Prefrontal Cortex/metabolism , Prefrontal Cortex/drug effects , Depression/drug therapy , Depression/metabolism , Depression/genetics , Mice , Antidepressive Agents/pharmacology , Male , Ketamine/pharmacology , ARNTL Transcription Factors/metabolism , ARNTL Transcription Factors/genetics , Circadian Rhythm/drug effects , Mice, Inbred C57BL , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Disease Models, Animal , Phenotype , Neuronal Plasticity/drug effects , Receptors, AMPA/metabolism , Receptors, AMPA/genetics , Nuclear Receptor Subfamily 1, Group D, Member 1/metabolism , Nuclear Receptor Subfamily 1, Group D, Member 1/genetics , Homer Scaffolding Proteins/metabolism , Homer Scaffolding Proteins/genetics , Neurons/metabolism , Neurons/drug effectsABSTRACT
The regulation of the circadian clock plays an important role in influencing physiological conditions. While it is reported that the timing and quantity of energy intake impact circadian regulation, the underlying mechanisms remain unclear. This study investigated the impact of dietary protein intake on peripheral clocks. Firstly, transcriptomic analysis was conducted to investigate molecular targets of low-protein intake. Secondly, mPer2::Luc knock-in mice, fed with either a low-protein, normal, or high-protein diet for 6 weeks, were analyzed for the oscillation of PER2 expression in peripheral tissues and for the expression profiles of circadian and metabolic genes. Lastly, the candidate pathway identified by the in vivo analysis was validated using AML12 cells. As a result, using transcriptomic analysis, we found that the low-protein diet hardly altered the circadian rhythm in the central clock. In animal experiments, expression levels and period lengths of PER2 were different in peripheral tissues depending on dietary protein intake; moreover, mRNA levels of clock-controlled genes and endoplasmic reticulum (ER) stress genes were affected by dietary protein intake. Induction of ER stress in AML12 cells caused an increased amplitude of Clock and Bmal1 and an advanced peak phase of Per2. This result shows that the intake of different dietary protein ratios causes an alteration of the circadian rhythm, especially in the peripheral clock of mice. Dietary protein intake modifies the oscillation of ER stress genes, which may play key roles in the regulation of the circadian clock.
Subject(s)
Circadian Rhythm , Dietary Proteins , Period Circadian Proteins , Animals , Mice , Circadian Rhythm/genetics , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolism , Dietary Proteins/administration & dosage , Endoplasmic Reticulum Stress , Circadian Clocks/genetics , Male , Mice, Inbred C57BL , Gene Expression Regulation/drug effects , CLOCK Proteins/genetics , CLOCK Proteins/metabolism , ARNTL Transcription Factors/genetics , ARNTL Transcription Factors/metabolism , Gene Expression Profiling , Cell Line , TranscriptomeABSTRACT
Circadian rhythm plays an important role in intestinal homeostasis and intestinal immune function. Circadian rhythm dysregulation was reported to induce intestinal microbiota dysbiosis, intestinal barrier disruption, and trigger intestinal inflammation. However, the relationship between intestinal microbiota metabolites and the circadian rhythm of the intestinal barrier was still unclear. Urolithin A (UA), a kind of intestinal microbial metabolite, was selected in this study. Results showed UA influenced on the expression rhythm of the clock genes BMAL1 and PER2 in intestinal epithelial cells. Furthermore, the study investigated the effects of UA on the expression rhythms of clock genes (BMAL1 and PER2) and tight junctions (OCLN, TJP1, and CLND1), all of which were dysregulated by inflammation. In addition, UA pre-treatment by oral administration to female C57BL/6 mice showed the improvement in the fecal IgA concentrations, tight junction expression (Clnd1 and Clnd4), and clock gene expression (Bmal1 and Per2) in a DSS-induced colitis model induced using DSS treatment. Finally, the Nrf2-SIRT1 signaling pathway was confirmed to be involved in UA's effect on the circadian rhythm of intestinal epithelial cells by antagonist treatment. This study also showed evidence that UA feeding showed an impact on the central clock, which are circadian rhythms in SCN. Therefore, this study highlighted the potential of UA in treating diseases like IBD with sleeping disorders by improving the dysregulated circadian rhythms in both the intestinal barrier and the SCN.
Subject(s)
Circadian Rhythm , Colitis , Coumarins , Intestinal Mucosa , Mice, Inbred C57BL , Animals , Circadian Rhythm/drug effects , Female , Intestinal Mucosa/metabolism , Intestinal Mucosa/drug effects , Colitis/chemically induced , Colitis/drug therapy , Colitis/metabolism , Mice , Coumarins/pharmacology , Gastrointestinal Microbiome/drug effects , Inflammation , NF-E2-Related Factor 2/metabolism , ARNTL Transcription Factors/metabolism , ARNTL Transcription Factors/genetics , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Tight Junctions/metabolism , Tight Junctions/drug effects , Signal Transduction/drug effects , Disease Models, Animal , Humans , Dextran Sulfate , Gene Expression Regulation/drug effects , Immunoglobulin A/metabolism , Sirtuin 1ABSTRACT
Epigenetic regulation is important for circadian rhythm. In previous studies, multiple histone modifications were found at the Period (Per) locus. However, most of these studies were not conducted in clock neurons. In our screen, we found that a CoREST mutation resulted in defects in circadian rhythm by affecting Per transcription. Based on previous studies, we hypothesized that CoREST regulates circadian rhythm by regulating multiple histone modifiers at the Per locus. Genetic and physical interaction experiments supported these regulatory relationships. Moreover, through tissue-specific chromatin immunoprecipitation assays in clock neurons, we found that the CoREST mutation led to time-dependent changes in corresponding histone modifications at the Per locus. Finally, we proposed a model indicating the role of the CoREST complex in the regulation of circadian rhythm. This study revealed the dynamic changes of histone modifications at the Per locus specifically in clock neurons. Importantly, it provides insights into the role of epigenetic factors in the regulation of dynamic gene expression changes in circadian rhythm.
Subject(s)
Circadian Rhythm , Co-Repressor Proteins , Epigenesis, Genetic , Neurons , Period Circadian Proteins , Animals , Neurons/metabolism , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Mice , Co-Repressor Proteins/metabolism , Co-Repressor Proteins/genetics , Histones/metabolism , Histone Code , Mutation , Circadian Clocks/genetics , Gene Expression RegulationABSTRACT
Steroidogenesis is associated with circadian clock genes. However, the regulation of steroid hormone production in sow granulosal cells by Per2, a crucial circadian regulator, remains unexplored. In this study, we have identified the presence of Per2 in ovarian granulosa cells and have observed its circadian expression pattern. Employing siRNA to interfere with Per2 expression, our investigation revealed that Per2 knockdown notably elevated progesterone (P4) levels along with increasing the expression of StAR but interference of Per2 did not alter the rhythm of clock-related gene (Bmal1, Clock, Per1, and Cry1) in granulosa cells. Subsequent mechanistic analysis showed that Per2 formed complexes with PPARγ and interference with Per2 promoted the formation of the PPARγ:RXRα heterodimer. Importantly, we uncovered that PPARγ:RXRα heterodimer could control the expression of StAR via direct peroxisome proliferator response element binding to its promoter to regulate its activity, and knockdown of Per2 promoted the transcription of StAR via increasing the binding of PPARγ:RXRα ligands. Altogether, these findings indicated a noncanonical role of Per2 in controlling PPARγ:RXRα binding to regulate transcription of StAR and progesterone synthesis, thus revealing potential avenues of pharmacological and therapeutic intervention.
The circadian clock can regulate ovarian function, and disruption of the circadian clock caused by environmental factors can seriously affect the reproductive capacity of female animals, leading to ovarian diseases. Therefore, it is necessary to investigate the relationship between clock genes and ovarian function. In this study, Per2, a key gene for the circadian clock, was expressed in ovarian granulosa cells according to a rhythmic pattern, but knocking out Per2 did not alter the circadian rhythm in granulosa cells. Interference of Per2 notably elevated progesterone (P4) levels along with increasing the expression of StAR (a key gene for P4 synthesis) in granulosa cells. Subsequent mechanistic analysis showed that knockdown of Per2 enhanced transcription of StAR by promoting the formation of the PPARγ:RXRα heterodimer. These results indicated a noncanonical role of Per2 in regulating PPARγ:RXRα binding to control transcription of StAR and P4 production.
Subject(s)
Gene Expression Regulation , Granulosa Cells , Period Circadian Proteins , Phosphoproteins , Progesterone , Animals , Granulosa Cells/metabolism , Female , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolism , Swine , Progesterone/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , PPAR gamma/genetics , PPAR gamma/metabolismABSTRACT
Copper (Cu) is known to induce oxidative stress and apoptosis in the liver, kidney, and brain. We previously demonstrated the molecular mechanism underlying the Cu-induced hepatic diurnal variation. However, the cellular molecule(s) involved in Cu-induced renal chronotoxicity remain unknown. In this study, we aimed to elucidate the molecular mechanisms underlying Cu-induced diurnal toxicity in the kidneys. We evaluated cell viability and clock gene expression levels in mouse renal cortex tubular cells (MuRTE61 cells) after Cu treatment. We also examined the Cu homeostasis- and apoptosis-related gene levels after period 1 (Per1) overexpression in MuRTE61 cells. Cu treatment decreased MuRTE61 cell viability in a dose-dependent manner. It increased the Per1 expression levels after 24 h. Notably, Per1 overexpression alleviated the Cu-induced inhibition of MuRTE61 cell viability. Moreover, Per1 overexpression downregulated the cleaved caspase-3 and reduced Cu levels by upregulating the antioxidant 1 copper chaperone (Atox1) levels. These results suggest that Cu-induced renal toxicity is associated with Per1 expression via the regulation of the copper chaperone, Atox1.
Subject(s)
Cell Survival , Copper , Kidney , Period Circadian Proteins , Animals , Mice , Copper/toxicity , Cell Survival/drug effects , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Kidney/metabolism , Kidney/drug effects , Apoptosis/drug effects , Cell Line , Gene Expression Regulation/drug effects , Oxidative Stress/drug effects , Copper Transport Proteins/metabolism , Copper Transport Proteins/genetics , Molecular Chaperones/metabolism , Molecular Chaperones/geneticsABSTRACT
BACKGROUND: Temporomandibular joint osteoarthritis (TMJOA) has a high incidence rate, but its pathogenesis remains unclear. Circadian rhythm is an important oscillation in the human body and influences various biological activities. However, it is still unclear whether circadian rhythm affects the onset and development of TMJOA. METHODS: We disrupted the normal rhythm of rats and examined the expression of core clock genes in the mandibular condylar cartilage of the jaw and histological changes in condyles. After isolating rat mandibular condylar chondrocytes, we upregulated or downregulated the clock gene Per1, examined the expression of cartilage matrix-degrading enzymes, tested the activation of the GSK3ß/ß-CATENIN pathway and verified it using agonists and inhibitors. Finally, after downregulating the expression of Per1 in the mandibular condylar cartilage of rats with jet lag, we examined the expression of cartilage matrix-degrading enzymes and histological changes in condyles. RESULTS: Jet lag led to TMJOA-like lesions in the rat mandibular condyles, and the expression of the clock gene Per1 and cartilage matrix-degrading enzymes increased in the condylar cartilage of rats. When Per1 was downregulated or upregulated in mandibular condylar chondrocytes, the GSK3ß/ß-CATENIN pathway was inhibited or activated, and the expression of cartilage matrix-degrading enzymes decreased or increased, which can be rescued by activator and inhibitor of the GSK3ß/ß-CATENIN pathway. Moreover, after down-regulation of Per1 in mandibular condylar cartilage in vivo, significant alleviation of cartilage degradation, cartilage loss, subchondral bone loss induced by jet lag, and inhibition of the GSK3ß/ß-CATENIN signaling pathway were observed. Circadian rhythm disruption can lead to TMJOA. The clock gene Per1 can promote the occurrence of TMJOA by activating the GSK3ß/ß-CATENIN pathway and promoting the expression of cartilage matrix-degrading enzymes. The clock gene Per1 is a target for the prevention and treatment of TMJOA.
Subject(s)
Chondrocytes , Circadian Rhythm , Glycogen Synthase Kinase 3 beta , Mandibular Condyle , Osteoarthritis , Period Circadian Proteins , Temporomandibular Joint , Up-Regulation , beta Catenin , Animals , Glycogen Synthase Kinase 3 beta/metabolism , Chondrocytes/metabolism , Chondrocytes/pathology , beta Catenin/metabolism , Osteoarthritis/pathology , Osteoarthritis/metabolism , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Mandibular Condyle/pathology , Mandibular Condyle/metabolism , Temporomandibular Joint/pathology , Temporomandibular Joint/metabolism , Male , Rats, Sprague-Dawley , Signal Transduction , RatsABSTRACT
Cisplatin (CDDP) is a cornerstone chemotherapeutic agent used to treat oral squamous cell carcinoma (OSCC) and many solid cancers. However, the mechanisms underlying tumor resistance to CDDP obscure the enhancement of its therapeutic efficacy. In this study, we unveil diminished expression of the biological clock gene PER2 in OSCC, negatively correlated with the expression of multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 1 (MRP1). The overexpression of PER2 suppressed MDR1 and MRP1 expression and increased intracellular CDDP levels and DNA damage, thereby bolstering OSCC cell sensitivity to CDDP. In vivo tumorigenic assays corroborated that PER2 overexpression notably increased OSCC sensitivity to CDDP, augmenting the suppression of OSCC tumorigenesis. Co-immunoprecipitation, GST pull-down, and cycloheximide tracking assays revealed that PER2, via its C-terminal domain, bound to and diminishes PDK1 stability. The degradation of PDK1 was further dependent on the suppression of the AKT/mTOR pathway to enhance the sensitivity of OSCC cells to CDDP. Our study supports PER2 as a target for improving CDDP sensitivity in OSCC, and the combination of PER2 and CDDP is a novel strategy with potential clinical therapeutic value.
Subject(s)
Cisplatin , Mouth Neoplasms , Proto-Oncogene Proteins c-akt , Signal Transduction , TOR Serine-Threonine Kinases , Cisplatin/pharmacology , Humans , Proto-Oncogene Proteins c-akt/metabolism , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Mouth Neoplasms/drug therapy , TOR Serine-Threonine Kinases/metabolism , Cell Line, Tumor , Animals , Signal Transduction/drug effects , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Mice, Nude , Drug Resistance, Neoplasm/drug effects , Mice , Pyruvate Dehydrogenase Acetyl-Transferring Kinase/metabolism , Multidrug Resistance-Associated Proteins/metabolism , ATP Binding Cassette Transporter, Subfamily B/metabolism , ATP Binding Cassette Transporter, Subfamily B/genetics , Male , Antineoplastic Agents/pharmacology , FemaleABSTRACT
N6-methyladenosine (m6A) is the most abundant epitranscriptomic mark that regulates the fate of RNA molecules. Recent studies have revealed a bidirectional interaction between m6A modification and the circadian clock. However, the precise temporal dynamics of m6A global enrichment in the central circadian pacemaker have not been fully elucidated. Our study investigates the relationship between FTO demethylase and molecular clocks in primary cells of the suprachiasmatic nucleus (SCN). In addition, we examined the effects of lipopolysaccharide (LPS) on Fto expression and the role of FTO in LPS-induced reactive oxygen species (ROS) production in primary SCN cell culture. We observed circadian rhythmicity in the global m6A levels, which mirrored the rhythmic expression of the Fto demethylase. Silencing FTO using siRNA reduced the mesor of Per2 rhythmicity in SCN primary cells and extended the period of the PER2 rhythm in SCN primary cell cultures from PER2::LUC mice. When examining the immune response, we discovered that exposure to LPS upregulated global m6A levels while downregulating Fto expression in SCN primary cell cultures. Interestingly, we found a loss of circadian rhythmicity in Fto expression following LPS treatment, indicating that the decrease of FTO levels may contribute to m6A upregulation without directly regulating its circadian rhythm. To explore potential protective mechanisms against neurotoxic inflammation, we examined ROS production following LPS treatment in SCN primary cell cultures pretreated with FTO siRNA. We observed a time-dependent pattern of ROS induction, with significant peak at 32 h but not at 20 h after synchronization. Silencing the FTO demethylase abolished ROS induction following LPS exposure, supporting the hypothesis that FTO downregulation serves as a protective mechanism during LPS-induced neuroinflammation in SCN primary cell cultures.
Subject(s)
Adenosine , Alpha-Ketoglutarate-Dependent Dioxygenase FTO , Circadian Clocks , Lipopolysaccharides , Suprachiasmatic Nucleus , Animals , Suprachiasmatic Nucleus/metabolism , Suprachiasmatic Nucleus/drug effects , Adenosine/analogs & derivatives , Adenosine/metabolism , Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism , Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics , Mice , Circadian Clocks/drug effects , Circadian Clocks/physiology , Circadian Clocks/genetics , Lipopolysaccharides/pharmacology , Neuroinflammatory Diseases/metabolism , Methylation/drug effects , Reactive Oxygen Species/metabolism , Male , Mice, Inbred C57BL , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Cells, Cultured , Circadian Rhythm/drug effects , Circadian Rhythm/physiology , RNA/genetics , RNA/metabolism , RNA MethylationABSTRACT
The circadian system is a conserved time-keeping machinery that regulates a wide range of processes such as sleep/wake, feeding/fasting, and activity/rest cycles to coordinate behavior and physiology. Circadian disruption can be a contributing factor in the development of metabolic diseases, inflammatory disorders, and higher risk of cancer. Glioblastoma (GBM) is a highly aggressive grade 4 brain tumor that is resistant to conventional therapies and has a poor prognosis after diagnosis, with a median survival of only 12-15 months. GBM cells kept in culture were shown to contain a functional circadian oscillator. In seeking more efficient therapies with lower side effects, we evaluated the pharmacological modulation of the circadian clock by targeting the cytosolic kinases glycogen synthase kinase-3 (GSK-3) and casein kinase 1 ε/δ (CK1ε/δ) with specific inhibitors (CHIR99021 and PF670462, respectively), the cryptochrome protein stabilizer (KL001), or circadian disruption after Per2 knockdown expression in GBM-derived cells. CHIR99021-treated cells had a significant effect on cell viability, clock protein expression, migration, and cell cycle distribution. Moreover, cultures exhibited higher levels of reactive oxygen species and alterations in lipid droplet content after GSK-3 inhibition compared to control cells. The combined treatment of CHIR99021 with temozolomide was found to improve the effect on cell viability compared to temozolomide therapy alone. Per2 disruption affected both GBM migration and cell cycle progression. Overall, our results suggest that pharmacological modulation or molecular clock disruption severely affects GBM cell biology.
Subject(s)
Brain Neoplasms , Glioblastoma , Glioblastoma/pathology , Glioblastoma/metabolism , Glioblastoma/drug therapy , Humans , Cell Line, Tumor , Brain Neoplasms/pathology , Brain Neoplasms/metabolism , Brain Neoplasms/drug therapy , Pyridines/pharmacology , Cell Survival/drug effects , Cytosol/metabolism , Cytosol/drug effects , Glycogen Synthase Kinase 3/metabolism , Pyrimidines/pharmacology , Cell Movement/drug effects , Circadian Clocks/drug effects , Circadian Clocks/physiology , CLOCK Proteins/metabolism , CLOCK Proteins/genetics , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Reactive Oxygen Species/metabolismABSTRACT
During postnatal cardiac hypertrophy, cardiomyocytes undergo mitotic exit, relying on DNA replication-independent mechanisms of histone turnover to maintain chromatin organization and gene transcription. In other tissues, circadian oscillations in nucleosome occupancy influence clock-controlled gene expression, suggesting a role for the circadian clock in temporal control of histone turnover and coordinated cardiomyocyte gene expression. We sought to elucidate roles for the master circadian transcription factor, Bmal1, in histone turnover, chromatin organization, and myocyte-specific gene expression and cell growth in the neonatal period. Bmal1 knockdown in neonatal rat ventricular myocytes decreased myocyte size, total cellular protein synthesis, and transcription of the fetal hypertrophic gene Nppb after treatment with serum or the α-adrenergic agonist phenylephrine. Depletion of Bmal1 decreased the expression of clock-controlled genes Per2 and Tcap, as well as Sik1, a Bmal1 target upregulated in adult versus embryonic hearts. Bmal1 knockdown impaired Per2 and Sik1 promoter accessibility as measured by micrococcal nuclease-quantitative PCR and impaired histone turnover as measured by metabolic labeling of acid-soluble chromatin fractions. Sik1 knockdown in turn decreased myocyte size, while simultaneously inhibiting natriuretic peptide B transcription and activating Per2 transcription. Linking these changes to chromatin remodeling, depletion of the replication-independent histone variant H3.3a inhibited myocyte hypertrophy and prevented phenylephrine-induced changes in clock-controlled gene transcription. Bmal1 is required for neonatal myocyte growth, replication-independent histone turnover, and chromatin organization at the Sik1 promoter. Sik1 represents a novel clock-controlled gene that coordinates myocyte growth with hypertrophic and clock-controlled gene transcription. Replication-independent histone turnover is required for transcriptional remodeling of clock-controlled genes in cardiac myocytes in response to growth stimuli.
Subject(s)
ARNTL Transcription Factors , Histones , Myocytes, Cardiac , Period Circadian Proteins , Animals , Histones/metabolism , ARNTL Transcription Factors/metabolism , ARNTL Transcription Factors/genetics , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/cytology , Rats , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Circadian Rhythm , Phenylephrine/pharmacology , Gene Expression Regulation, Developmental , Heart/growth & development , Heart/embryology , Animals, Newborn , Cardiomegaly/metabolism , Cardiomegaly/genetics , Cardiomegaly/pathology , Rats, Sprague-Dawley , Chromatin Assembly and Disassembly , Cells, Cultured , Promoter Regions, GeneticABSTRACT
Chronic disruption of circadian rhythms by night shift work is associated with an increased breast cancer risk. However, little is known about the impact of night shift on peripheral circadian genes (CGs) and circadian-controlled genes (CCGs) associated with breast cancer. Hence, we assessed central clock markers (melatonin and cortisol) in plasma, and peripheral CGs (PER1, PER2, PER3, and BMAL1) and CCGs (ESR1 and ESR2) in peripheral blood mononuclear cells (PBMCs). In day shift nurses (n = 12), 24-h rhythms of cortisol and melatonin were aligned with day shift-oriented light/dark schedules. The mRNA expression of PER2, PER3, BMAL1, and ESR2 showed 24-h rhythms with peak values in the morning. In contrast, night shift nurses (n = 10) lost 24-h rhythmicity of cortisol with a suppressed morning surge but retained normal rhythmic patterns of melatonin, leading to misalignment between cortisol and melatonin. Moreover, night shift nurses showed disruption of rhythmic expressions of PER2, PER3, BMAL1, and ESR2 genes, resulting in an impaired inverse correlation between PER2 and BMAL1 compared to day shift nurses. The observed trends of disrupted circadian markers were recapitulated in additional day (n = 20) and night (n = 19) shift nurses by measurement at early night and midnight time points. Taken together, this study demonstrated the misalignment of cortisol and melatonin, associated disruption of PER2 and ESR2 circadian expressions, and internal misalignment in peripheral circadian network in night shift nurses. Morning plasma cortisol and PER2, BMAL1, and ESR2 expressions in PBMCs may therefore be useful biomarkers of circadian disruption in shift workers.
Subject(s)
Circadian Clocks , Circadian Rhythm , Hydrocortisone , Melatonin , Shift Work Schedule , Humans , Female , Melatonin/metabolism , Melatonin/blood , Adult , Shift Work Schedule/adverse effects , Circadian Clocks/genetics , Hydrocortisone/blood , Hydrocortisone/metabolism , Circadian Rhythm/physiology , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolism , Nurses , Leukocytes, Mononuclear/metabolism , Estrogen Receptor alpha/metabolism , Estrogen Receptor alpha/genetics , Estrogen Receptor beta/metabolism , Estrogen Receptor beta/genetics , ARNTL Transcription Factors/genetics , ARNTL Transcription Factors/metabolism , Work Schedule Tolerance/physiology , Working ConditionsABSTRACT
The duration of the transcription-repression cycles that give rise to mammalian circadian rhythms is largely determined by the stability of the PERIOD (PER) protein, the rate-limiting components of the molecular clock. The degradation of PERs is tightly regulated by multisite phosphorylation by casein kinase 1 (CK1δ/ε). In this phosphoswitch, phosphorylation of a PER2 degron [degron 2 (D2)] causes degradation, while phosphorylation of the PER2 familial advanced sleep phase (FASP) domain blocks CK1 activity on the degron, stabilizing PER2. However, this model and many other studies of PER2 degradation do not include the second degron of PER2 that is conserved in PER1, termed degron 1 (D1). We examined how these two degrons contribute to PER2 stability, affect the balance of the phosphoswitch, and how they are differentiated by CK1. Using PER2-luciferase fusions and real-time luminometry, we investigated the contribution of both D2 and of CK1-PER2 binding. We find that D1, like D2, is a substrate of CK1 but that D1 plays only a 'backup' role in PER2 degradation. Notably, CK1 bound to a PER1:PER2 dimer protein can phosphorylate PER1 D1 in trans. This scaffolded phosphorylation provides additional levels of control to PER stability and circadian rhythms.
Subject(s)
Period Circadian Proteins , Protein Stability , Humans , Casein Kinase I/metabolism , Casein Kinase I/genetics , Circadian Rhythm , Degrons , HEK293 Cells , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Phosphorylation , ProteolysisABSTRACT
The circadian clock is the inner rhythm of life activities and is controlled by a self-sustained and endogenous molecular clock, which maintains a ~ 24 h internal oscillation. As the core element of the circadian clock, BMAL1 is susceptible to degradation through the ubiquitin-proteasome system (UPS). Nevertheless, scant information is available regarding the UPS enzymes that intricately modulate both the stability and transcriptional activity of BMAL1, affecting the cellular circadian rhythm. In this work, we identify and validate UBR5 as a new E3 ubiquitin ligase that interacts with BMAL1 by using affinity purification, mass spectrometry, and biochemical experiments. UBR5 overexpression induced BMAL1 ubiquitination, leading to diminished stability and reduced protein level of BMAL1, thereby attenuating its transcriptional activity. Consistent with this, UBR5 knockdown increases the BMAL1 protein. Domain mapping discloses that the C-terminus of BMAL1 interacts with the N-terminal domains of UBR5. Similarly, cell-line-based experiments discover that HYD, the UBR5 homolog in Drosophila, could interact with and downregulate CYCLE, the BMAL1 homolog in Drosophila. PER2-luciferase bioluminescence real-time reporting assay in a mammalian cell line and behavioral experiments in Drosophila reveal that UBR5 or hyd knockdown significantly reduces the period of the circadian clock. Therefore, our work discovers a new ubiquitin ligase UBR5 that regulates BMAL1 stability and circadian rhythm and elucidates the underlying molecular mechanism. This work provides an additional layer of complexity to the regulatory network of the circadian clock at the post-translational modification level, offering potential insights into the modulation of the dysregulated circadian rhythm.
Subject(s)
ARNTL Transcription Factors , Circadian Rhythm , Ubiquitin-Protein Ligases , Ubiquitination , Ubiquitin-Protein Ligases/metabolism , Ubiquitin-Protein Ligases/genetics , ARNTL Transcription Factors/metabolism , ARNTL Transcription Factors/genetics , Animals , Humans , Circadian Rhythm/physiology , HEK293 Cells , Proteolysis , Circadian Clocks/physiology , Period Circadian Proteins/metabolism , Period Circadian Proteins/geneticsABSTRACT
Polymethoxyflavonoids, such as nobiletin (abundant in Citrus depressa), have been reported to have antioxidant, anti-inflammatory, anticancer, and anti-dementia effects, and are also a circadian clock modulator through retinoic acid receptor-related orphan receptor (ROR) α/γ. However, the optimal timing of nobiletin intake has not yet been determined. Here, we explored the time-dependent treatment effects of nobiletin and a possible novel mechanistic idea for nobiletin-induced circadian clock regulation in mice. In vivo imaging showed that the PER2::LUC rhythm in the peripheral organs was altered in accordance with the timing of nobiletin administration (100 mg/kg). Administration at ZT4 (middle of the light period) caused an advance in the peripheral clock, whereas administration at ZT16 (middle of the dark period) caused an increase in amplitude. In addition, the intraperitoneal injection of nobiletin significantly and potently stimulated corticosterone and adrenaline secretion and caused an increase in Per1 expression in the peripheral tissues. Nobiletin inhibited phosphodiesterase (PDE) 4A1A, 4B1, and 10A2. Nobiletin or rolipram (PDE4 inhibitor) injection, but not SR1078 (RORα/γ agonist), caused acute Per1 expression in the peripheral tissues. Thus, the present study demonstrated a novel function of nobiletin and the regulation of the peripheral circadian clock.
Subject(s)
Circadian Clocks , Corticosterone , Flavones , Animals , Flavones/pharmacology , Circadian Clocks/drug effects , Mice , Male , Corticosterone/blood , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Epinephrine , Mice, Inbred C57BL , Nuclear Receptor Subfamily 1, Group F, Member 1/metabolism , Circadian Rhythm/drug effects , Circadian Rhythm/physiologyABSTRACT
In mammals, CLOCK and BMAL1 proteins form a heterodimer that binds to E-box sequences and activates transcription of target genes, including Period (Per). Translated PER proteins then bind to the CLOCK-BMAL1 complex to inhibit its transcriptional activity. However, the molecular mechanism and the impact of this PER-dependent inhibition on the circadian clock oscillation remain elusive. We previously identified Ser38 and Ser42 in a DNA-binding domain of CLOCK as phosphorylation sites at the PER-dependent inhibition phase. In this study, knockout rescue experiments showed that nonphosphorylatable (Ala) mutations at these sites shortened circadian period, whereas their constitutive-phospho-mimetic (Asp) mutations completely abolished the circadian rhythms. Similarly, we found that nonphosphorylatable (Ala) and constitutive-phospho-mimetic (Glu) mutations at Ser78 in a DNA-binding domain of BMAL1 also shortened the circadian period and abolished the rhythms, respectively. The mathematical modeling predicted that these constitutive-phospho-mimetic mutations weaken the DNA binding of the CLOCK-BMAL1 complex and that the nonphosphorylatable mutations inhibit the PER-dependent displacement (reduction of DNA-binding ability) of the CLOCK-BMAL1 complex from DNA. Biochemical experiments supported the importance of these phosphorylation sites for displacement of the complex in the PER2-dependent inhibition. Our results provide direct evidence that phosphorylation of CLOCK-Ser38/Ser42 and BMAL1-Ser78 plays a crucial role in the PER-dependent inhibition and the determination of the circadian period.
Subject(s)
ARNTL Transcription Factors , CLOCK Proteins , Circadian Clocks , Period Circadian Proteins , Animals , Humans , Mice , ARNTL Transcription Factors/metabolism , ARNTL Transcription Factors/genetics , ARNTL Transcription Factors/chemistry , Circadian Clocks/genetics , Circadian Rhythm/physiology , Circadian Rhythm/genetics , CLOCK Proteins/metabolism , CLOCK Proteins/genetics , DNA/metabolism , HEK293 Cells , Mutation , NIH 3T3 Cells , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Phosphorylation , Protein Binding , Protein DomainsABSTRACT
Chromatin organization plays a crucial role in gene regulation by controlling the accessibility of DNA to transcription machinery. While significant progress has been made in understanding the regulatory role of clock proteins in circadian rhythms, how chromatin organization affects circadian rhythms remains poorly understood. Here, we employed ATAC-seq (Assay for Transposase-Accessible Chromatin with Sequencing) on FAC-sorted Drosophila clock neurons to assess genome-wide chromatin accessibility at dawn and dusk over the circadian cycle. We observed significant oscillations in chromatin accessibility at promoter and enhancer regions of hundreds of genes, with enhanced accessibility either at dusk or dawn, which correlated with their peak transcriptional activity. Notably, genes with enhanced accessibility at dusk were enriched with E-box motifs, while those more accessible at dawn were enriched with VRI/PDP1-box motifs, indicating that they are regulated by the core circadian feedback loops, PER/CLK and VRI/PDP1, respectively. Further, we observed a complete loss of chromatin accessibility rhythms in per01 null mutants, with chromatin consistently accessible at both dawn and dusk, underscoring the critical role of Period protein in driving chromatin compaction during the repression phase at dawn. Together, this study demonstrates the significant role of chromatin organization in circadian regulation, revealing how the interplay between clock proteins and chromatin structure orchestrates the precise timing of biological processes throughout the day. This work further implies that variations in chromatin accessibility might play a central role in the generation of diverse circadian gene expression patterns in clock neurons.